Safety and efficacy profile of pembrolizumab in solid cancer: pooled reanalysis based on randomized controlled trials

BACKGROUND: The aim of the present review is to systematically evaluate the efficacy and safety of pembrolizumab by analyzing survival outcomes and at the same time, to present evidence for future clinical applications of anti-programmed cell death protein 1 (anti-PD-1) antibodies by analyzing the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Manni, Ma, Xuelei, Guo, Linghong, Xia, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628692/
https://www.ncbi.nlm.nih.gov/pubmed/29033546
http://dx.doi.org/10.2147/DDDT.S146286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628692/
https://www.ncbi.nlm.nih.gov/pubmed/29033546
http://dx.doi.org/10.2147/DDDT.S146286

Ejemplares similares